You can buy or sell BPMC and other stocks, options, ETFs, and crypto commission-free!
Blueprint Medicines Corporation Common Stock, also called Blueprint Medicines, is a precision therapy company. It focuses on medicines to improve the lives of patients with genomically defined cancers, rare diseases and cancer immunotherapy. Read More The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy on October 14, 2008 and is headquartered in Cambridge, MA.
52 Week High
52 Week Low
— per share
Expected May 7, Pre-Market